| Identification | More | [Name]
3-CHLORO-2,4-DIFLUORONITROBENZENE | [CAS]
3847-58-3 | [Synonyms]
2,4-DIFLUORO-3-CHLORONITROBENZENE
2-CHLORO-1,3-DIFLUORO-4-NITRO-BENZENE
3-CHLORO-2,4-DIFLUORONITROBENZENE
3-Chloro-2,4-difluoronitrobenzene 97%
3-Chloro-2,4-difluoronitrobenzene97%
6014 2,4-DIFLUORO-3-CHLORO NITRO BENZENE | [EINECS(EC#)]
411-980-8 | [Molecular Formula]
C6H2ClF2NO2 | [MDL Number]
MFCD00042201 | [Molecular Weight]
193.54 | [MOL File]
3847-58-3.mol |
| Chemical Properties | Back Directory | [Appearance]
light yellow crystal powde | [Melting point ]
41-43°C | [Boiling point ]
243.0±35.0 °C(Predicted) | [density ]
1.591±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
soluble in Methanol | [form ]
powder to crystal | [color ]
White to Light yellow | [CAS DataBase Reference]
3847-58-3(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
C,N | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .
R50/53:Very Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment .
R43:May cause sensitization by skin contact.
R34:Causes burns.
R22:Harmful if swallowed. | [Safety Statements ]
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) .
S61:Avoid release to the environment. Refer to special instructions safety data sheet .
S60:This material and/or its container must be disposed of as hazardous waste .
S28:After contact with skin, wash immediately with plenty of ... (to be specified by the manufacturer) .
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S22:Do not breathe dust . | [RIDADR ]
1759 | [Hazard Note ]
Corrosive | [HazardClass ]
8 | [PackingGroup ]
II | [HS Code ]
2904990090 |
| Hazard Information | Back Directory | [Chemical Properties]
light yellow crystal powde | [Uses]
3-Chloro-2,4-difluoronitrobenzene is a pharmaceutical intermediate, which is reported in the literature to be used for the preparation of LSD1 inhibitors and selective HER2 inhibitors. |
|
|